| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Tobramycin |
| Brand | TOBI Podhaler® |
| Indication | For the suppressive therapy of chronic pulmonary infection due to Ps aeruginosa in adults and children aged 6 years and older with CF. |
| Assessment Process | |
| Rapid review commissioned | 03/11/2010 |
| Rapid review completed | 29/11/2010 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |